BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

956 related articles for article (PubMed ID: 16563815)

  • 1. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE; Siegel F
    Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The assessment of platelet function in patients with essential thrombocythemia].
    Treliński J; Tybura M; Chojnowski K
    Pol Merkur Lekarski; 2008 Jul; 25(145):19-22. PubMed ID: 18839608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A; Südhoff T; Meierkord F
    Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
    Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
    Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils.
    Falanga A; Marchetti M; Barbui T; Smith CW
    Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.
    Cesar JM; de Miguel D; García Avello A; Burgaleta C
    Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
    Barbui T; Finazzi G
    Curr Hematol Rep; 2003 May; 2(3):248-56. PubMed ID: 12901347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
    Arellano-Rodrigo E; Alvarez-Larrán A; Reverter JC; Colomer D; Villamor N; Bellosillo B; Cervantes F
    Am J Hematol; 2009 Feb; 84(2):102-8. PubMed ID: 19105233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the Platelet Function Analyzer (PFA)-100 and platelet aggregometry in the differentiation of essential thrombocythemia from reactive thrombocytosis.
    Tsantes AE; Dimoula A; Bonovas S; Mantzios G; Tsirigotis P; Zoi K; Kalamara E; Kardoulaki A; Sitaras N; Travlou A; Dervenoulas J; Vaiopoulos G
    Thromb Res; 2010 Feb; 125(2):142-6. PubMed ID: 19664802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
    Landolfi R; Cipriani MC; Novarese L
    Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment.
    Reményi G; Szász R; Debreceni IB; Szarvas M; Batár P; Nagy B; Kappelmayer J; Udvardy M
    Platelets; 2013; 24(6):486-92. PubMed ID: 23216455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular complications of essential thrombocythemia].
    Bellucci S
    Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of megakaryocytic and erythroid colony formation and platelet function tests on the risk of thromboembolic and bleeding complications in essential thrombocythaemia.
    Niittyvuopio R; Juvonen E; Kekomäki R; Oksanen K; Anttila P; Ruutu T
    Eur J Haematol; 2004 Apr; 72(4):245-51. PubMed ID: 15089761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
    Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
    Nurden P; Bihour C; Smith M; Raymond JM; Nurden AT
    Am J Hematol; 1996 Jan; 51(1):79-84. PubMed ID: 8571943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
    Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
    Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).
    Sacchi S; Vinci G; Gugliotta L; Rupoli S; Gargantini L; Martinelli V; Baravelli S; Lazzarino M; Finazzi G
    Haematologica; 2000 May; 85(5):492-5. PubMed ID: 10800165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.